Abattis Bioceuticals Corp. (OTCPK:ATTB.F) announced a non-brokered private placement of 13,333,333 units at a price of CAD 0.60 per unit for gross proceeds of CAD 8,000,000 on January 10, 2018. Each unit will consist of one common share and one half of one common share purchase warrant. Each warrant will be exercisable for one share at an exercise price of CAD 0.85 per share for a period of three years from the closing date. In the event that the shares trade at a price per share on the Canadian Securities Exchange of greater than CAD 1 for a period of 10 consecutive trading days, the company may accelerate the expiry date of the warrants by giving notice to the holders thereof and, in such case, the warrants will expire on the thirtieth day after the date of such notice. The company reserves an over-allotment option to increase the offering by up to 15%.